Min-Hyo Ki

545 total citations
13 papers, 444 citations indexed

About

Min-Hyo Ki is a scholar working on Pharmaceutical Science, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Min-Hyo Ki has authored 13 papers receiving a total of 444 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmaceutical Science, 4 papers in Molecular Biology and 3 papers in Organic Chemistry. Recurrent topics in Min-Hyo Ki's work include Advanced Drug Delivery Systems (4 papers), Surfactants and Colloidal Systems (2 papers) and Hydrogels: synthesis, properties, applications (2 papers). Min-Hyo Ki is often cited by papers focused on Advanced Drug Delivery Systems (4 papers), Surfactants and Colloidal Systems (2 papers) and Hydrogels: synthesis, properties, applications (2 papers). Min-Hyo Ki collaborates with scholars based in South Korea. Min-Hyo Ki's co-authors include Dae‐Duk Kim, ChangJu Chun, Mi-Ran Park, Soo‐Chang Song, Chong‐Su Cho, Sungjoon Cho, Dong‐Hwan Kim, Jung‐Sun Kim, Ji-Eon Kim and Hyun‐Jong Cho and has published in prestigious journals such as Biomaterials, Cancer Research and Journal of Controlled Release.

In The Last Decade

Min-Hyo Ki

12 papers receiving 438 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Min-Hyo Ki South Korea 10 140 128 120 96 77 13 444
Jin Ki Kim South Korea 14 164 1.2× 92 0.7× 91 0.8× 35 0.4× 23 0.3× 20 571
Luis Ignacio Tártara Argentina 14 224 1.6× 103 0.8× 118 1.0× 74 0.8× 34 0.4× 23 534
Jorge Montanari Argentina 17 165 1.2× 94 0.7× 203 1.7× 73 0.8× 30 0.4× 35 622
M Ahmed Egypt 10 249 1.8× 61 0.5× 177 1.5× 51 0.5× 28 0.4× 24 547
Shafi Ullah Pakistan 12 132 0.9× 70 0.5× 71 0.6× 60 0.6× 40 0.5× 19 364
Ping Gao China 11 117 0.8× 94 0.7× 168 1.4× 71 0.7× 29 0.4× 14 632
Rishikesh Gupta India 11 387 2.8× 199 1.6× 159 1.3× 37 0.4× 53 0.7× 20 673
Azadeh Alinaghi Australia 8 302 2.2× 68 0.5× 77 0.6× 32 0.3× 34 0.4× 10 486
Pradip Thakor India 9 163 1.2× 114 0.9× 83 0.7× 36 0.4× 25 0.3× 10 489
Stefan Hönzke Germany 12 264 1.9× 101 0.8× 104 0.9× 53 0.6× 32 0.4× 14 591

Countries citing papers authored by Min-Hyo Ki

Since Specialization
Citations

This map shows the geographic impact of Min-Hyo Ki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min-Hyo Ki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min-Hyo Ki more than expected).

Fields of papers citing papers by Min-Hyo Ki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Min-Hyo Ki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min-Hyo Ki. The network helps show where Min-Hyo Ki may publish in the future.

Co-authorship network of co-authors of Min-Hyo Ki

This figure shows the co-authorship network connecting the top 25 collaborators of Min-Hyo Ki. A scholar is included among the top collaborators of Min-Hyo Ki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Min-Hyo Ki. Min-Hyo Ki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Choi, Miri, Ae‐Kyeong Kim, Joo‐Youn Lee, et al.. (2021). Aristolactam BIII, a naturally derived DYRK1A inhibitor, rescues Down syndrome-related phenotypes. Phytomedicine. 92. 153695–153695. 14 indexed citations
2.
Hong, Sung-Pyo, et al.. (2020). Abstract 4212: SJP1602, a selective and dual inhibitor of FAK and Pyk2 for treatment of triple negative breast cancer. Cancer Research. 80(16_Supplement). 4212–4212. 1 indexed citations
3.
Hasan, Nurhasni, Jiafu Cao, Juho Lee, et al.. (2019). Bacteria-Targeted Clindamycin Loaded Polymeric Nanoparticles: Effect of Surface Charge on Nanoparticle Adhesion to MRSA, Antibacterial Activity, and Wound Healing. Pharmaceutics. 11(5). 236–236. 80 indexed citations
5.
Ki, Min-Hyo, et al.. (2015). An injectable liquid crystal system for sustained delivery of entecavir. International Journal of Pharmaceutics. 490(1-2). 265–272. 26 indexed citations
6.
Ki, Min-Hyo, So‐Hyun Park, Ji-Eon Kim, et al.. (2014). A new injectable liquid crystal system for one month delivery of leuprolide. Journal of Controlled Release. 185. 62–70. 57 indexed citations
8.
Ki, Min-Hyo, et al.. (2014). Chitosan-Based Hybrid Nanocomplex for siRNA Delivery and Its Application for Cancer Therapy. Pharmaceutical Research. 31(12). 3323–3334. 21 indexed citations
9.
Kim, Dong‐Hwan, et al.. (2014). Lyotropic liquid crystal systems in drug delivery: a review. Journal of Pharmaceutical Investigation. 45(1). 1–11. 95 indexed citations
10.
Park, Mi-Ran, et al.. (2010). Sustained delivery of human growth hormone using a polyelectrolyte complex-loaded thermosensitive polyphosphazene hydrogel. Journal of Controlled Release. 147(3). 359–367. 68 indexed citations
11.
Park, Mi-Ran, et al.. (2009). Cationic and thermosensitive protamine conjugated gels for enhancing sustained human growth hormone delivery. Biomaterials. 31(6). 1349–1359. 40 indexed citations
12.
Ki, Min-Hyo, et al.. (2008). The efficacy and safety of clopidogrel resinate as a novel polymeric salt form of clopidogrel. Archives of Pharmacal Research. 31(2). 250–258. 17 indexed citations
13.
Kim, Jaehyun, Su‐Kyung Lee, Min-Hyo Ki, et al.. (2004). Development of parenteral formulation for a novel angiogenesis inhibitor, CKD-732 through complexation with hydroxypropyl-β-cyclodextrin. International Journal of Pharmaceutics. 272(1-2). 79–89. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026